Evofem Biosciences, Inc. (EVFM)

Evofem Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	0.69	0.58	2.77	7.73	48.89	15.57
Short-Term Investments	0	0	0	0	0	8.23
Cash & Cash Equivalents	0.69	0.58	2.77	7.73	48.89	23.8
Cash Growth	7.82%	-79.05%	-64.19%	-84.19%	105.39%	1689.77%
Receivables	4.31	5.74	1.13	6.45	1.32	0.69
Inventory	1.31	1.7	5.38	7.67	7.16	1.28
Other Current Assets	0.62	1.2	3.43	-2.62	40.36	0.66
Total Current Assets	6.92	9.21	12.7	19.24	97.73	26.42
Property, Plant & Equipment	1.26	1.31	8.35	11.17	11.19	0.55
Long-Term Investments	0	0	0.8	0.8	0.8	0.25
Other Long-Term Assets	0.04	0.03	3.32	0.29	0.25	1.07
Total Long-Term Assets	1.29	1.34	12.46	12.26	12.24	1.87
Total Assets	8.22	10.55	25.16	19.24	109.97	28.3
Accounts Payable	16.29	17.02	14.98	10.32	10.64	6.01
Deferred Revenue	0	0	0	13.02	10.99	0
Current Debt	42.41	43.37	68	111.26	54.7	0.2
Other Current Liabilities	15.54	12.08	10.85	3.07	0.95	6.45
Total Current Liabilities	74.24	72.46	93.83	137.66	77.28	12.66
Long-Term Debt	0	0.01	3.13	4.42	31.24	0
Other Long-Term Liabilities	-0	0	0	-127.59	0.1	0
Total Long-Term Liabilities	0	0.01	3.13	-123.17	31.34	0
Total Liabilities	74.24	72.47	96.96	14.5	108.62	12.66
Total Debt	42.41	43.37	71.13	115.68	85.94	0.2
Debt Growth	-23.57%	-39.02%	-38.51%	34.61%	43524.37%	-95.09%
Common Stock	0.01	0	0.01	0.02	0.01	0.01
Retained Earnings	-893.56	-888.7	-938.69	-860.68	-655.49	-513.18
Comprehensive Income	-0.53	-0.85	49.53	5.09	0	0
Shareholders' Equity	-66.03	-61.92	-71.8	4.74	1.35	15.64
Total Liabilities and Equity	8.22	10.55	25.16	19.24	109.97	28.3
Net Cash / Debt	-41.72	-42.79	-68.36	-107.95	-37.05	23.61
Net Cash Per Share	-1.34	-0.04	-145.44	-1542.14	-926.20	1180.35
Working Capital	-67.32	-63.25	-81.13	-118.43	20.45	13.76
Book Value Per Share	-2.12	-12.82	-152.77	67.71	33.67	781.80

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.